NCT03078322 AV-101 as Adjunct Antidepressant Therapy in Patients With Major Depression Status COMPLETED Phase PHASE2
NCT03072823 Omega-3 Polyunsaturated Fatty Acids on Major Depressive Disorder in Patients With Cardiovascular Diseases Status COMPLETED Phase NA
NCT03067506 Cognitive and Mood Assessment Data in Major Depressive Disorder Using Digital Wearable Technology Status COMPLETED Phase N/A
NCT03065335 Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder Status RECRUITING Phase PHASE1
NCT03062267 Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness Status COMPLETED Phase NA
NCT03053830 Open Label Ketamine Treatment for Major Depressive Disorder in Veterans Status COMPLETED Phase PHASE2
NCT03051074 Examining the Effects of Reduced Environmental Stimulation on Anxiety Status COMPLETED Phase NA
NCT03031665 Sex, Hormones and Gamma-Aminobutyric Acid (GABA) in Stress Induced Anhedonia in Depression Status COMPLETED Phase N/A
NCT03009448 The Experience of Older Adults Facing Depression for the First Time in Old Age Status UNKNOWN Phase N/A
NCT02983838 Research on Pathophysiology and Treatment in Depression Using Brain Derived Neurotrophic Factor and Amyloid Neuroimaging Status UNKNOWN Phase N/A
NCT02980484 fMRI-neuronavigated rTMS for the Treatment of Major Depression Associated With TBI Status TERMINATED Phase PHASE2
NCT02972632 Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder Status COMPLETED Phase PHASE4